Morphine dependence is associated with changes in neuropeptide S receptorexpression and function in rat brain

Peptides

Volumn 46, Issue , 2013, Pages 6-12

  Ghazal, Pasha ^a   Ciccocioppo, Roberto ^a   Ubaldi, Massimo ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Abuse; Addiction; Anxiety; Dependence; Gene expression; Morphine withdrawal; NPS; Rat

Indexed keywords

MESSENGER RNA; MORPHINE; NALOXONE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; MAZE TEST; MORPHINE ADDICTION; NONHUMAN; OPIATE ADDICTION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STRIA TERMINALIS; TRANQUILIZING ACTIVITY; VENTRAL TEGMENTUM;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ABUSE; ADDICTION; ANXIETY; DEPENDENCE; GENE EXPRESSION; MORPHINE WITHDRAWAL; NPS; RAT;

ANIMALS; ANXIETY; BRAIN; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84884997820     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.05.001     Document Type: Article

References (36)

1. Badia-Elder NE, Henderson AN, Bertholomey ML, Dodge NC, Stewart RB.The effects of neuropeptide S on ethanol drinking and other related behav-iors in alcohol-preferring and-nonpreferring rats. Alcohol Clin Exp Res2008;32:1380-7.
2. Beck B, Fernette B, Stricker-Krongrad A. Peptide S is a novel potent inhibitor ofvoluntary and fast-induced food intake in rats. Biochem Biophys Res Commun2005;332:859-65.
3. Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, et al.Persistent increase of alcohol-seeking evoked by neuropeptide S: an effectmediated by the hypothalamic hypocretin system. Neuropsychopharmacology2009;34:2125-34.
4. Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M. The role of the neu-ropeptide S system in addiction: focus on its interaction with the CRF andhypocretin/orexin neurotransmission. Prog Neurobiol 2012;100:48-59.
5. Cifani C, Micioni Di Bonaventura MV, Cannella N, Fedeli A, Guerrini R, CaloG, et al. Effect of neuropeptide S receptor antagonists and partial agonists onpalatable food consumption in the rat. Peptides 2011;32:44-50.
6. Cruz AP, Frei F, Graeff FG. Ethopharmacological analysis of rat behavior on theelevated plus-maze. Pharmacol Biochem Behav 1994;49:171-6.
7. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats andhumans: role of the extended amygdala in fear vs anxiety. Neuropsychophar-macology 2010;35:105-35.
8. Fedeli A, Braconi S, Economidou D, Cannella N, Kallupi M, Guerrini R, et al. Theparaventricular nucleus of the hypothalamus is a neuroanatomical substratefor the inhibition of palatable food intake by neuropeptide S. Eur J Neurosci2009;30:1594-602.
9. Hurd YL, Herkenham M. Molecular alterations in the neostriatum of humancocaine addicts. Synapse 1993;13:357-69.
10. Jungling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD, et al.Neuropeptide S-mediated control of fear expression and extinction: role ofintercalated GABAergic neurons in the amygdala. Neuron 2008;59:298-310.
11. Kallupi M, Cannella N, Economidou D, Ubaldi M, Ruggeri B, Weiss F, et al.Neuropeptide S facilitates cue-induced relapse to cocaine seeking throughactivation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A2010;107:19567-72.
12. Kallupi M, de Guglielmo G, Cannella N, Li HW, Calo G, Guerrini R, et al. Hypothal-amic Neuropeptide S receptor blockade decreases discriminative cue-inducedreinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 2012.
13. Koob GF. A role for brain stress systems in addiction. Neuron 2008;59:11-34.
14. Koob GF. Neurobiological substrates for the dark side of compulsivity in addic-tion. Neuropharmacology 2009;56(1):18-31.
15. Lage R, Gonzalez CR, Dieguez C, Lopez M. Nicotine treatment regu-lates neuropeptide S system expression in the rat brain. Neurotoxicology2007;28:1129- 35.
16. Leonard SK, Ring RH. Immunohistochemical localization of the neuropeptide Sreceptor in the rat central nervous system. Neuroscience 2011;172:153-63.
17. Li W, Gao YH, Chang M, Peng YL, Yao J, Han RW, et al. Neuropeptide S inhibitsthe acquisition and the expression of conditioned place preference to morphinein mice. Peptides 2009;30:234-40.
18. Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement ofethanol seeking: exacerbation by history of dependence and role of concurrentactivation of corticotropin-releasing factor and opioid mechanisms. J Neurosci2002;22:7856-61.
19. Liu X, Zeng J, Zhou A, Theodorsson E, Fahrenkrug J, Reinscheid RK. Molecularfingerprint of neuropeptide S-producing neurons in the mouse brain. J CompNeurol 2011;519:1847-66.
20. Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, Munsch T. Identifi-cation of a neuropeptide S responsive circuitry shaping amygdala activity viathe endopiriform nucleus. PLoS ONE 2008:2008.
21. Okamura N, Garau C, Duangdao DM, Clark SD, Jungling K, Pape HC, et al.Neuropeptide S enhances memory during the consolidation phase and inter-acts with noradrenergic systems in the brain. Neuropsychopharmacology2011;36:744-52.
22. Paneda C, Huitron-Resendiz S, Frago LM, Chowen JA, Picetti R, de Lecea L, et al.Neuropeptide S reinstates cocaine-seeking behavior and increases locomotoractivity through corticotropin-releasing factor receptor 1 in mice. J Neurosci2009;29:4155-61.
23. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. San Diego,CA: Academic Press; 1988.
24. Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activityin an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol BiochemBehav 1986;24:525-9.
25. Rawls SM, Baron DA, Kim J. beta-Lactam antibiotic inhibits development ofmorphine physical dependence in rats. Behav Pharmacol 2010;21:161-4.
26. Reinscheid RK, Xu Y-L. Neuropeptide S and its receptor: a newly deorphanizedG protein-coupled receptor system. Neuroscientist 2005;11:532-8.
27. Reinscheid RK, Xu YL, Okamura N, Zeng J, Chung S, Pai R, et al. Pharmacologi-cal characterization of human and murine neuropeptide S receptor variants. JPharmacol Exp Ther 2005;315:1338-45.
28. Rizzi A, Vergura R, Marzola G, Ruzza C, Guerrini R, Salvadori S, et al. Neuro-peptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br JPharmacol 2008;154:471-9.
29. Ruggeri B, Braconi S, Cannella N, Kallupi M, Soverchia L, Ciccocioppo R, et al.Neuropeptide S receptor gene expression in alcohol withdrawal and pro-tracted abstinence in postdependent rats. Alcohol Clin Exp Res 2010;34:90-7.
30. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of imageanalysis. Nat Methods 2012;9:671-5.
31. Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitatedmorphine withdrawal and concurrent activation of the nucleus accumbensshell. Biol Psychiatry 2008;64:175-83.
32. Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV,et al. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis andinhibits food intake. Endocrinology 2006;147:3510-8.
33. Vitale G, Filaferro M, Ruggieri V, Pennella S, Frigeri C, Rizzi A, et al.Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides2008;29:2286-91.
34. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, et al. Compulsivedrug-seeking behavior and relapse. Neuroadaptation, stress, and conditioningfactors. Ann N Y Acad Sci 2001;937:1-26.
35. Xu Y-L, Gall CM, Jackson VR, Civelli O, Reinscheid RK. Distribution ofneuropeptide S receptor mRNA and neurochemical characteristics of neu-ropeptide S-expressing neurons in the rat brain. J Comp Neurol 2007;500:84-102.
36. Xu Y-L, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, et al.Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.Neuron 2004;43:487-97.